Abstract: The present invention provides a compound which is a nystatin derivative having an additional double bond present between C28 and C29 and which is further modified relative to nystatin at one or more of positions C5, C7, C9, C10, C11, C16 or at the amino group of mycosamine.
Type:
Application
Filed:
March 8, 2013
Publication date:
January 30, 2014
Applicant:
BIOSERGEN AS
Inventors:
Sergey Borisovich ZOTCHEV, Sven Even Finn BORGOS, Trygve BRAUTASET, Trond Erling ELLINGSEN, Evgenia Nikolaevna OLSUFYEVA, Maria Nikolaevna PREOBRAZHENSKAYA, Havard SLETTA